MedTrace Logo

Testing the Helpfulness of 2 Decision Aids for Prostate Cancer

NCT00432601 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1028

Last updated 2016-03-22

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to test different methods for communicating information about prostate cancer treatment to men. The investigators are studying how best to present information so men can make informed decisions about what prostate cancer treatment to undergo.

Conditions

Interventions

BEHAVIORAL

type of decision aid

We will be comparing two decision aids (MCC vs. NCCN) in terms of their impact on decision making and patient-physician communication.

Sponsors & Collaborators

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • Angela Fagerlin, PhD MA · VA Ann Arbor Healthcare System

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2012-09-30
Completion
2012-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00432601 on ClinicalTrials.gov